1 Introduction to Research & Analysis Reports 1.1 Cushing’s Disease Treatment Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Cushing’s Disease Treatment Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Cushing’s Disease Treatment Overall Market Size 2.1 China Cushing’s Disease Treatment Market Size: 2021 VS 2027 2.2 China Cushing’s Disease Treatment Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Cushing’s Disease Treatment Players in China Market 3.2 Top China Cushing’s Disease Treatment Companies Ranked by Revenue 3.3 China Cushing’s Disease Treatment Revenue by Companies 3.4 Top 3 and Top 5 Cushing’s Disease Treatment Companies in China Market, by Revenue in 2020 3.5 Companies Cushing’s Disease Treatment Product Type 3.6 Tier 1, Tier 2 and Tier 3 Cushing’s Disease Treatment Players in China Market 3.6.1 List of Tier 1 Cushing’s Disease Treatment Companies in China 3.6.2 List of Tier 2 and Tier 3 Cushing’s Disease Treatment Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Cushing’s Disease Treatment Market Size Markets, 2021 & 2027 4.1.2 Ketoconazole 4.1.3 Mitotane 4.1.4 Aminoglutethimide 4.1.5 Metyrapone 4.1.6 Mifepristone 4.1.7 Etomidate 4.1.8 Pasireotide 4.2 By Type - China Cushing’s Disease Treatment Revenue & Forecasts 4.2.1 By Type - China Cushing’s Disease Treatment Revenue, 2016-2021 4.2.2 By Type - China Cushing’s Disease Treatment Revenue, 2022-2027 4.2.3 By Type - China Cushing’s Disease Treatment Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Cushing’s Disease Treatment Market Size, 2021 & 2027 5.1.2 Hospital Pharmacies 5.1.3 Retail Pharmacies 5.1.4 Drug Stores 5.1.5 Clinics 5.1.6 E-Commerce/Online Pharmacies 5.2 By Application - China Cushing’s Disease Treatment Revenue & Forecasts 5.2.1 By Application - China Cushing’s Disease Treatment Revenue, 2016-2021 5.2.2 By Application - China Cushing’s Disease Treatment Revenue, 2022-2027 5.2.3 By Application - China Cushing’s Disease Treatment Revenue Market Share, 2016-2027 6 Cushing’s Disease Treatment Companies Profiles 6.1 CORCEPT THERAPEUTICS 6.1.1 CORCEPT THERAPEUTICS Company Details 6.1.2 CORCEPT THERAPEUTICS Business Overview 6.1.3 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Introduction 6.1.4 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Revenue in China Market (2016-2021) 6.1.5 CORCEPT THERAPEUTICS Recent Developments 6.2 HRA Pharma 6.2.1 HRA Pharma Company Details 6.2.2 HRA Pharma Business Overview 6.2.3 HRA Pharma Cushing’s Disease Treatment Introduction 6.2.4 HRA Pharma Cushing’s Disease Treatment Revenue in China Market (2016-2021) 6.2.5 HRA Pharma Recent Developments 6.3 Strongbridge Biopharma 6.3.1 Strongbridge Biopharma Company Details 6.3.2 Strongbridge Biopharma Business Overview 6.3.3 Strongbridge Biopharma Cushing’s Disease Treatment Introduction 6.3.4 Strongbridge Biopharma Cushing’s Disease Treatment Revenue in China Market (2016-2021) 6.3.5 Strongbridge Biopharma Recent Developments 6.4 Novartis 6.4.1 Novartis Company Details 6.4.2 Novartis Business Overview 6.4.3 Novartis Cushing’s Disease Treatment Introduction 6.4.4 Novartis Cushing’s Disease Treatment Revenue in China Market (2016-2021) 6.4.5 Novartis Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Cushing’s Disease Treatment Market Opportunities & Trends in China Market Table 2. Cushing’s Disease Treatment Market Drivers in China Market Table 3. Cushing’s Disease Treatment Market Restraints in China Market Table 4. Key Players of Cushing’s Disease Treatment in China Market Table 5. Top Cushing’s Disease Treatment Players in China Market, Ranking by Revenue (2019) Table 6. China Cushing’s Disease Treatment Revenue by Companies, (US$, Mn), 2016-2021 Table 7. China Cushing’s Disease Treatment Revenue Share by Companies, 2016-2021 Table 8. Companies Cushing’s Disease Treatment Product Type Table 9. List of Tier 1 Cushing’s Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Cushing’s Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – China Cushing’s Disease Treatment Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - China Cushing’s Disease Treatment Revenue (US$, Mn), 2016-2021 Table 13. By Type - China Cushing’s Disease Treatment Revenue (US$, Mn), 2022-2027 Table 14. By Application – China Cushing’s Disease Treatment Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - China Cushing’s Disease Treatment Revenue (US$, Mn), 2016-2021 Table 16. By Application - China Cushing’s Disease Treatment Revenue (US$, Mn), 2022-2027 Table 17. CORCEPT THERAPEUTICS Company Details Table 18. CORCEPT THERAPEUTICS Business Overview Table 19. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Product Table 20. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 21. CORCEPT THERAPEUTICS Recent Developments Table 22. HRA Pharma Company Details Table 23. HRA Pharma Business Overview Table 24. HRA Pharma Cushing’s Disease Treatment Product Table 25. HRA Pharma Cushing’s Disease Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 26. HRA Pharma Recent Developments Table 27. Strongbridge Biopharma Company Details Table 28. Strongbridge Biopharma Business Overview Table 29. Strongbridge Biopharma Cushing’s Disease Treatment Product Table 30. Strongbridge Biopharma Cushing’s Disease Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 31. Strongbridge Biopharma Recent Developments Table 32. Novartis Company Details Table 33. Novartis Business Overview Table 34. Novartis Cushing’s Disease Treatment Product Table 35. Novartis Cushing’s Disease Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 36. Novartis Recent Developments List of Figures Figure 1. Cushing’s Disease Treatment Segment by Type Figure 2. Cushing’s Disease Treatment Segment by Application Figure 3. China Cushing’s Disease Treatment Market Overview: 2020 Figure 4. China Cushing’s Disease Treatment Market Size: 2021 VS 2027 (US$, Mn) Figure 5. China Cushing’s Disease Treatment Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Cushing’s Disease Treatment Revenue in 2020 Figure 7. By Type - China Cushing’s Disease Treatment Revenue Market Share, 2016-2027 Figure 8. By Application - China Cushing’s Disease Treatment Revenue Market Share, 2016-2027 Figure 9. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. HRA Pharma Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Strongbridge Biopharma Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Novartis Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

CORCEPT THERAPEUTICS HRA Pharma Strongbridge Biopharma Novartis